FindTrial
Sign In

To study the effects of two medicaments (MTA and 3Mixtatin) for the treatment of carious primary molars by vital pulp therapy (pulpotomy).

Comparative evaluation of the treatment outcomes of pulpotomy in primary molars using MTA and 3Mixtatin: A randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017853
Enrollment
32
Registered
2019-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified

Interventions

Intervention1: 3MIXTATIN: A powdered combination of 100mg ciprofloxacin, 100mg metronidazole , 100mg cefixime and 2 mg Simvastatin will be mixed with normal saline and delivered to radicular pulp stum

Sponsors

Dr Anam Mushtaq
Lead Sponsor
Dr Anam Mushtaq
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Clinically: 1. History of localized pain lasting for a short duration which subsides upon elimination of causative mechanical or thermal stimulus. 2.Carious lesions involving more than half the dentin thickness. 3. Recent History of spontaneous pain of momentary duration not exceeding 7 days. 4. Hemorrhage control achievable within 3-5 minutes during the procedure. 5. Restorable crown structure Radiographically 1. Carious lesion approximating pulp. 2. Absence of any periradicular or furcal pathology. 3. No pathologic external or internal root resorption.

Exclusion criteria

Exclusion criteria: Clinically: 1. History of lingering, Spontaneous and Nocturnal pain which is continuous even after removal of the stimuli. 2. Sensitivity to Hot Stimulus. 3. Tenderness on percussion. 4. Pathologic tooth mobility. 5. Vestibular obliteration and swelling in relation to the tooth 6. Draining sinus tract in relation to the tooth. 7. Grossly carious teeth with unrestorable crown structure. Radiographically 1. Widened PDL space. 2. More than 1/3rd physiologic root resorption 3. Presence of periradicularor Periapical radiolucency. 4. Pathologic external or internal resorption 5. Calcifications within pulp

Design outcomes

Primary

MeasureTime frame
Maintaining radicular pulp vitality and assessing it clinically by (a)Absence of spontaneous pain and/or sensitivity to percussion and palpation, fistula / swelling, pathological mobility. (b) Radiographic success by Absence of periodontal ligament space widening , radiolucency at the periapical region, internal root resorption or external root resorption.Timepoint: 3 months, 6 months and 12 months—

Secondary

MeasureTime frame
Maintenance of tooth function and asymptomatic stateTimepoint: At the end of 1 year ( 12 months)—

Countries

India

Contacts

Public ContactDrMousumi Goswami

ITS Dental college , hospital and research centre, Greater Noida, UP

mousumi87goswami@gmail.com08588854190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026